TYK Medicines, Inc. Class H (HK:2410) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TYK Medicines, Inc., a PRC-based joint stock company, has announced the submission of an application for the full circulation of its H shares. This move could convert 173,641,645 unlisted shares into H shares, allowing them to be traded on the Hong Kong Stock Exchange’s Main Board, enhancing liquidity and potentially increasing investor interest.
For further insights into HK:2410 stock, check out TipRanks’ Stock Analysis page.